Emergence of cowpox: study of the virulence of clinical strains and evaluation of antivirals

• Published in: PloS one 2013-02, Vol.8 (2), p.e55808
• Main Authors: Duraffour, Sophie, Mertens, Barbara, Meyer, Hermann, van den Oord, Joost J, Mitera, Tania, Matthys, Patrick, Snoeck, Robert, Andrei, Graciela
• Format: Article
• Language: English
• Subjects: Animal tissues; Animals; Antiviral agents; Antiviral Agents - therapeutic use; Bacterial infections; Biology; Biomarkers; Cell Line; Chemotherapy; Cidofovir; Clinical isolates; Comparative analysis; Cowpox; Cowpox - blood; Cowpox - drug therapy; Cowpox - pathology; Cowpox - virology; Cowpox virus - drug effects; Cowpox virus - genetics; Cowpox virus - pathogenicity; Cowpox virus - physiology; Deoxyribonucleic acid; DNA; Female; Gene expression; Genotypes; Humans; Infection; Infections; Interleukin 6; Interleukin-6 - blood; Laboratory animals; Lung - pathology; Lung - virology; Lungs; Mice; Microtus agrestis; Organs; Pathogenicity; Pathogens; Phylogeny; Smallpox; Species classification; Strains (organisms); Tumor Necrosis Factor-alpha - blood; Veterinary Science; Virology; Virulence; Virulence (Microbiology); Viruses
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0055808

The last years, cowpox infections are being increasingly reported through Eurasia. Cowpox viruses (CPXVs) have been reported to have different genotypes and may be subdivided in at least five genetically distinct monophyletic clusters. However, little is known about their in vitro and in vivo features. In this report, five genetically diverse CPXVs, including one reference strain (CPXV strain Brighton) and four clinical isolates from human and animal cases, were compared with regard to growth in cells, pathogenicity in mice and inhibition by antivirals. While all CPXVs replicated similarly in vitro and showed comparable antiviral susceptibility, marked discrepancies were seen in vivo, including differences in virulence with recorded mortality rates of 0%, 20% and 100%. The four CPXV clinical isolates appeared less pathogenic than two reference strains, CPXV Brighton and vaccinia virus Western-Reserve. Disease severity seemed to correlate with high viral DNA loads in several organs, virus titers in lung tissues and levels of IL-6 cytokine in the sera. Our study highlighted that the species CPXV consists of viruses that not only differ considerably in their genotypes but also in their in vivo phenotypes, indicating that CPXVs should not be longer classified as a single species. Lung virus titers and IL-6 cytokine level in mice may be used as biomarkers for predicting disease severity. We further demonstrated the potential benefit of cidofovir, CMX001 and ST-246 use as antiviral therapy.